When was Genome Medical founded?

Genome Medical was founded in 2016 and raised its 1st funding round 1 year after it was founded.

Where is Genome Medical located?

Genome Medical is headquartered in Monterey, United States. It is registered at South San Francisco, California.

Who is the current CEO of Genome Medical?

Lisa Alderson of Genome Medical.

How many employees does Genome Medical have?

As of Apr 30, 2026, the latest employee count at Genome Medical is 76.

Is Genome Medical a funded company?

Genome Medical is a funded company, having raised a total of $173M across 6 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on May 25, 2017.

When was the latest funding round of Genome Medical?

Genome Medical's latest funding was a $***** Series D round on Sep 10, 2024, with participation from 0 investor.

Where does Genome Medical rank among its competitors?

Genome Medical ranks 5th amongst 70 active competitors, of which 18 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Aspira Women's Health, which secured $1.48M in Jun, 2026.

Who are the top competitors of Genome Medical?

Genome Medical's top competitors include Invitae, Myriad Genetics and Fulgent Genetics. Among them, Aspira Women's Health secured the most recent funding round in June, 2026.

Genome Medical - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of clinical and DTC genomic testing services. The company offers genomic testing services to consumers and healthcare providers in the areas of reproductive genetics, cancer genetics, cardiovascular diseases, and pediatrics as well as direct to consumer tests for assessment of the risk of various medical conditions.

Website: www.genomemedical.com/
Social
Phone Number: +1 **********
Registered Address: South San Francisco, California

Key Metrics

Founded Year

2016

Location

Monterey, United States

Stage

Series D

Total Funding

$173M in 6 rounds

Latest Funding Round

Series D, Sep 10, 2024, $*****

Investors

Canaan & 22 more

Ranked

5^th among 70 active competitors

Employee Count

76 as on Apr 30, 2026

Investment & Acquisitions

GeneMatters

Similar Companies

Invitae & 88 more

View Genome Medical's full profile

Genome Medical is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
GENOME MEDICAL INC. CIN: 815279149 , United States, Active	Dec 26, 999	-	100 (As on Dec 31, 2024)	-
GENOME MEDICAL, INC. CIN: 32072302378 , United States, Deadpooled	Oct 21, 2019	-	-	-

Genome Medical has raised a total funding of $173M over 6 rounds. Its first funding round was on May 25, 2017. Genome Medical has 23 institutional investors.

Here is the list of recent funding rounds of Genome Medical:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 10, 2024	2859583	Series D	5780660	6720080	6649894	1026734
Aug 30, 2021	5643325	Series C	1121651	3202996	2506356	Google Ventures & 14 more
Jul 01, 2020	5896744	Series B	3850158	3297301	Samsung Catalyst Fund	Canaan & 12 more

Access funding benchmarks and valuations. Sign up today!

View details of Genome Medical's funding rounds and investors

The founders of Genome Medical are Randy Scott, Lisa Alderson and Robert Green.

Here are the details of Genome Medical's key team members:

Randy Scott: Co-Founder of Genome Medical and founder of 1 other company. They serve on the boards of 3 companies.
Contact Info: 2 email addresses
Lisa Alderson: Co-Founder & CEO of Genome Medical.
Contact Info: 1 email address
Robert Green: Co-Founder of Genome Medical.
Contact Info: 1 email address

View details of Genome Medical's Founder profiles and Board Members

Genome Medical's employee count trend

Genome Medical has 76 employees as of Apr 26. Here is Genome Medical's employee count trend over the years:

Uncover Genome Medical's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Genome Medical include Invitae, Myriad Genetics and Fulgent Genetics. Here is the list of Top 10 competitors of Genome Medical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Invitae 2010, San Francisco (United States), Public	Provider of home-based genetic test for individuals	$190M	Deerfield, Perceptive Advisors & 22 others	77/100
2nd	Myriad Genetics 1991, United States, Public	Developer of molecular diagnostics and personalized medicine for cancer	-	Grayhawk Capital, New Venturetec & 6 others	72/100
3rd	Fulgent Genetics 2011, Temple City (United States), Acquired	Provider of genetic testing services for carrier screening cardiovascular diseases, epilepsy and cancer	$34.8M	-	71/100
4th	Celmatix 2009, New York City (United States), Series C	Pioneering ovarian health therapeutics for women's unique biological needs	$24.9M	Topspin Consumer Partners, Partnership for New York City ... & 4 others	66/100
5th	Genome Medical 2016, Monterey (United States), Series D	Provider of clinical and DTC genomic testing services	$173M	Samsung Catalyst Fund, Google Ventures & 21 others	58/100
6th	Blueprint Genetics 2012, Espoo (Finland), Acquired	Provider of genetic diagnostics and clinical interpretation for hereditary diseases	$26.2M	Inventure, MTIP & 4 others	51/100
7th	Aspira Women's Health 1993, Austin (United States), Public	Provider of diagnostic solution for ovarian malignancy in women	-	-	50/100
8th	Mira Dx 2008, New Haven (United States), Series A	miRNA-based diagnostic tests	$7.16M	Connecticut Innovations, Westway Capital	50/100
9th	AnchorDx 2015, Guangzhou (China), Series C	Developer of high throughput gene sequencing platform for clinical application	$73M	Orbimed, Frontline BioVentures & 5 others	48/100
10th	Recombine 2011, New York City (United States), Acquired	Genetic testing services	$12.1M	FirstMark, Vast Ventures & 3 others	48/100